JPMorgan Chase & Co. lifted its position in shares of SPDR S&P China ETF (NYSEARCA:GXC – Free Report) by 424.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,122 shares of the company’s stock after purchasing an additional 3,336 shares during the quarter. JPMorgan Chase & Co. owned 0.06% of SPDR S&P China ETF worth $313,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Osborne Partners Capital Management LLC raised its holdings in SPDR S&P China ETF by 0.3% during the 4th quarter. Osborne Partners Capital Management LLC now owns 193,401 shares of the company’s stock worth $14,675,000 after buying an additional 572 shares during the period. swisspartners Advisors Ltd increased its position in shares of SPDR S&P China ETF by 2.1% during the fourth quarter. swisspartners Advisors Ltd now owns 135,047 shares of the company’s stock worth $10,247,000 after acquiring an additional 2,740 shares in the last quarter. Summit Trail Advisors LLC increased its position in shares of SPDR S&P China ETF by 1.9% during the fourth quarter. Summit Trail Advisors LLC now owns 16,772 shares of the company’s stock worth $1,273,000 after acquiring an additional 306 shares in the last quarter. Avestar Capital LLC bought a new stake in SPDR S&P China ETF in the 4th quarter valued at $756,000. Finally, Pasadena Private Wealth LLC bought a new stake in SPDR S&P China ETF in the 4th quarter valued at $4,794,000.
SPDR S&P China ETF Trading Up 3.3 %
Shares of NYSEARCA GXC opened at $84.20 on Friday. The firm has a market cap of $421 million, a PE ratio of 11.81 and a beta of 0.31. The company has a fifty day moving average price of $83.72 and a 200 day moving average price of $80.23. SPDR S&P China ETF has a 1-year low of $64.69 and a 1-year high of $97.17.
SPDR S&P China ETF Profile
SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.
Featured Stories
- Five stocks we like better than SPDR S&P China ETF
- How to buy stock: A step-by-step guide for beginners
- Meta Takes A Bow With Q1 Earnings – Watch For Tariff Impact in Q2
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious
- Comparing and Trading High PE Ratio Stocks
- Palantir Earnings: 1 Bullish Signal and 1 Area of Concern
Want to see what other hedge funds are holding GXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P China ETF (NYSEARCA:GXC – Free Report).
Receive News & Ratings for SPDR S&P China ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P China ETF and related companies with MarketBeat.com's FREE daily email newsletter.